Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs6791462 | chr3:156081835 | A/G | 4.93E-11 | 178 | 25.67 | 24.97 | 10.3 | KM Plot |
PCPG | rs67923642 | chr8:135487402 | G/A | 4.15E-5 | 170 | 25.2 | 24.7 | 16.83 | KM Plot |
PCPG | rs6793815 | chr3:80452014 | C/T | 0.000273 | 174 | 25.47 | 25.87 | 25.17 | KM Plot |
PCPG | rs6794037 | chr3:194789163 | C/T | 0.000204 | 178 | 12.22 | 28.03 | 25.28 | KM Plot |
PCPG | rs67940783 | chr2:241527282 | G/A | 3.68E-5 | 177 | 25.97 | 20.2 | 10.3 | KM Plot |
PCPG | rs67943377 | chr12:21641984 | C/A | 3.36E-8 | 172 | 25.4 | 25.67 | 2.28 | KM Plot |
PCPG | rs6797622 | chr3:195734915 | C/T | 1.24E-5 | 177 | 24.52 | 31.47 | 13.38 | KM Plot |
PCPG | rs6797628 | chr3:195734933 | C/T | 1.19E-5 | 178 | 24.52 | 30.9 | 13.38 | KM Plot |
PCPG | rs6800032 | chr3:136622560 | C/T | 0.000447 | 174 | 24.1 | 28.3 | 23.83 | KM Plot |
PCPG | rs68031725 | chr14:74505692 | C/A | 0.000221 | 175 | 25.4 | 27.43 | 10.43 | KM Plot |
PCPG | rs68078235 | chr14:74513640 | G/A | 0.000221 | 175 | 25.4 | 27.43 | 10.43 | KM Plot |
PCPG | rs68112555 | chr14:74618207 | TTAAAA/T | 4.31E-7 | 177 | 25.4 | 27.78 | 7.4 | KM Plot |
PCPG | rs68123811 | chr14:74559588 | C/T | 2.57E-5 | 174 | 25.47 | 26.57 | 10.3 | KM Plot |
PCPG | rs684773 | chr3:135956305 | A/C | 8.79E-5 | 178 | 25.17 | 25.7 | 24.7 | KM Plot |
PCPG | rs6870207 | chr5:171529721 | A/G | 0.000131 | 175 | 25.77 | 24.23 | 17.12 | KM Plot |